These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 31614449)

  • 1. Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?
    Abedon ST
    Antibiotics (Basel); 2019 Oct; 8(4):. PubMed ID: 31614449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
    Schmalstig AA; Freidy S; Hanafin PO; Braunstein M; Rao GG
    Clin Pharmacol Ther; 2021 Jun; 109(6):1443-1456. PubMed ID: 33615463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of
    Danis-Wlodarczyk KM; Cai A; Chen A; Gittrich MR; Sullivan MB; Wozniak DJ; Abedon ST
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.
    Lin DM; Koskella B; Lin HC
    World J Gastrointest Pharmacol Ther; 2017 Aug; 8(3):162-173. PubMed ID: 28828194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
    Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
    Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria.
    Hasan M; Ahn J
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a Novel Jumbo Bacteriophage Effective Against
    Lewis R; Clooney AG; Stockdale SR; Buttimer C; Draper LA; Ross RP; Hill C
    Front Med (Lausanne); 2020; 7():67. PubMed ID: 32185177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
    Segall AM; Roach DR; Strathdee SA
    Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage and Bacterial Susceptibility, Resistance, and Tolerance to Antibiotics.
    Chen Q; Dharmaraj T; Cai PC; Burgener EB; Haddock NL; Spakowitz AJ; Bollyky PL
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections.
    Abedon ST
    Adv Drug Deliv Rev; 2019 May; 145():18-39. PubMed ID: 31708017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage exploitation of bacterial biofilms: phage preference for less mature targets?
    Abedon ST
    FEMS Microbiol Lett; 2016 Feb; 363(3):. PubMed ID: 26738755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage therapy for respiratory infections.
    Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecology of Anti-Biofilm Agents I: Antibiotics versus Bacteriophages.
    Abedon ST
    Pharmaceuticals (Basel); 2015 Sep; 8(3):525-58. PubMed ID: 26371010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage-Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency.
    Liu C; Hong Q; Chang RYK; Kwok PCL; Chan HK
    Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.